Form D · Biotechnology
VERENIUM CORP
San Diego, CA · CIK 0001049210
Offering snapshot reported Dec 19, 2012 · SEC filing
- Reported sold
- $7.31M Offering amount: $7.31M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 6, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 19, 2012 | Initial | $7,309,564 | No comparison | 2 | SEC filing |
| Oct 2, 2009 | Amendment | $13,707,000 | $893,000vs Sep 15, 2009 | 8 | SEC filing |
| Sep 15, 2009 | Initial | $12,814,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-188608
Includes $7,309,564.32 which the Issuer may receive upon the exercise of certain warrants.
Source: Form D, filed Dec 19, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William H. Baum | Executive |
| Jeffrey Black | Executive |
| James H. Cavanaugh | Director |
| John F. Dee | Director |
| Alexander A Fitzpatrick | Executive |
| Gerald M. Haines | Executive |
| John B. Howe | Executive |
| Peter Johnson | Director |
| Nell Jones | Executive |
| Fernand Kaufman | Director |
| Fernand Kaufmann | Director |
| James Levine | Director, Executive |
| Gregory Powers | Executive |
| Simon Rich | Director |
| Carlos A. Riva | Director, Executive |
| Janet Roemer | Executive |
| Joshua Ruch | Director |
| Cheryl Wenzinger | Director |
| Michael Zak | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3550 John Hopkins Court
San Diego, CA, 92121
San Diego, CA, 92121